Literature DB >> 28230

Hyperphenylalaninaemia due to dihydropteridine reductase deficiency.

H Gröbe, K Bartholome, S Milstien, S Kaufman.   

Abstract

Two siblings with increased levels of serum phenylalanine were detected by newborn screening. The older sibling deteriorated neurologically and mentally, despite early dietary control, and died at the age of 6 1/2 years. In the younger sibling phenylalanine hydroxylase activity in liver tissue was normal. Further investigations revealed increased concentrations of biopterin derivatives in the blood, a low excretion of 5-hydroxyindole acetic acid in the urine, and a dihydropteridine reductase deficiency as the cause of hyperphenylalaninaemia. The parents of the siblings showed 50% of the normal dihydropteridine reductase activity in their fibroblasts grown in culture. Neurotransmitter therapy was started in the second child at the age of 6 months and this was followed by distinct neurological and mental improvement.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 28230     DOI: 10.1007/BF00442368

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  Phenylketonuria due to a deficiency of dihydropteridine reductase.

Authors:  S Kaufman; N A Holtzman; S Milstien; L J Butler; A Krumholz
Journal:  N Engl J Med       Date:  1975-10-16       Impact factor: 91.245

2.  Atypical phenylketonuria with normal dihydropteridine reductase activity.

Authors:  F Rey; F Blandin-Savoja; J Rey
Journal:  N Engl J Med       Date:  1976-11-11       Impact factor: 91.245

3.  [Hyperphenylalaninaemia with normal phenylalanine-hydroxylase activity and a deficiency of tetrahydrobiopterin and dihydropteridine reductase].

Authors:  F Rey; J P Harpey; R J Leeming; J A Blair; J Aicardi; J Rey
Journal:  Arch Fr Pediatr       Date:  1977 Aug-Sep

4.  Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain.

Authors:  P A Friedman; A H Kappelman; S Kaufman
Journal:  J Biol Chem       Date:  1972-07-10       Impact factor: 5.157

5.  The analysis of indolic tryptophan metabolites in human urine. Thin-layer chromatography and in situ quantitation.

Authors:  D J Byrd; W Kochen; D Idzko; E Knorr
Journal:  J Chromatogr       Date:  1974-07-17

6.  Letter: A new molecular defect in phenylketonuria.

Authors:  K Bartholome
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

Review 7.  The phenylalanine hydroxylating system from mammalian liver.

Authors:  S Kaufman
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1971

8.  Letter: Variant forms of phenylketonuria.

Authors:  D M Danks; R G Cotton; P Schlesinger
Journal:  Lancet       Date:  1976-06-05       Impact factor: 79.321

9.  Letter: L-dopa and 5-hydroxytryptophan therapy in phenylketonuria with normal phenylalanine-hydroxylase activity.

Authors:  K Bartholomé; D J Byrd
Journal:  Lancet       Date:  1975-11-22       Impact factor: 79.321

10.  New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction.

Authors:  I Smith; B E Clayton; O H Wolff
Journal:  Lancet       Date:  1975-05-17       Impact factor: 79.321

View more
  9 in total

1.  Hyperphenylalaninemia due to impaired dihydrobiopterin biosynthesis.

Authors:  T Tanaka; K Aihara; K Iwai; M Kohashi; K Tomita; K Narisawa; N Arai; H Yoshida; T Usui
Journal:  Eur J Pediatr       Date:  1981-07       Impact factor: 3.183

2.  The study of the full spectrum of variants leading to hyperphenylalaninemia have revealed 10 new variants in the PAH gene.

Authors:  I Kuznetcova; P Gundorova; O Ryzhkova; A Polyakov
Journal:  Metab Brain Dis       Date:  2019-07-22       Impact factor: 3.584

3.  Dihydropteridine reductase variation in man and the characid fish "Cheirodon axelrodi": evidence for a dimeric enzyme structure.

Authors:  P Kuhl; K Olek; P Wardenbach
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

4.  Assignment of a gene for human quinoid-dihydropteridine reductase (QDPR, EC 1.6.5.1) to chromosome 4.

Authors:  P Kuhl; K Olek; P Wardenbach; K H Grzeschik
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

5.  Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin.

Authors:  R R McInnes; S Kaufman; J J Warsh; G R Van Loon; S Milstien; G Kapatos; S Soldin; P Walsh; D MacGregor; W B Hanley
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

6.  Dihydrobiopterin biosynthesis deficiency.

Authors:  J L Dhondt; B Leroux; J P Farriaux; C Largilliere; R J Leeming
Journal:  Eur J Pediatr       Date:  1983-12       Impact factor: 3.183

7.  [Molecular basis for the heterogeneity of phenylketonuria].

Authors:  K Bartholomé
Journal:  Naturwissenschaften       Date:  1980-10

8.  Basal ganglion calcification in hyperphenylalaninemia due to deficiency of dihydropteridine reductase.

Authors:  H Schmidt; K Ullrich; R Korinthenberg; P E Peters
Journal:  Pediatr Radiol       Date:  1988

9.  Hyperphenylalaninaemia caused by defects in biopterin metabolism.

Authors:  S Kaufman
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.